Related Experiment Video
Updated: Jan 12, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Envisioning a Multidisciplinary HBV Cure Research Agenda.
Karine Dubé1, Ali Ahmed2, Chari Cohen3
1Division of Infectious Diseases and Global Public Health, University of California San Diego School of Medicine, 9500 Gilman Drive, 0507, La Jolla, CA, USA. kdube@health.ucsd.edu.
Hepatitis B cure research needs a multidisciplinary approach, integrating social sciences, ethics, community engagement, and implementation science for equitable and scalable solutions. Addressing stigma and co-infections is crucial for effective hepatitis B (HBV) cure strategies.
Area of Science:
- Public Health
- Social Sciences
- Medical Ethics
Background:
- Hepatitis B virus (HBV) infection remains a global health challenge requiring innovative cure strategies.
- Current research on HBV cure is increasingly recognizing the need for a multidisciplinary approach.
Purpose of the Study:
- To review the current understanding of multidisciplinary aspects in hepatitis B cure research.
- To identify gaps and areas requiring further attention in the field.
Main Methods:
- Literature review of peer-reviewed publications.
- Analysis of socio-behavioral sciences, ethics, community engagement, and translational/implementation science aspects.
Main Results:
- The literature on multidisciplinary HBV cure research is expanding but has deficiencies.
- Key areas needing attention include treatment discontinuation acceptability, HBV-related stigma, co-infection impacts (e.g., HIV), and resource-limited setting implementation.
- A multidisciplinary framework is essential for developing effective, acceptable, scalable, and equitable HBV cures.
Conclusions:
- A comprehensive, multidisciplinary approach is vital for advancing hepatitis B cure research.
- Integrating social, ethical, and implementation sciences will facilitate the development of accessible and effective HBV cures worldwide.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
05:55Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chronic Pancreatitis II: Collaborative Care
Assessment: